CVS Health stock is trading -24.45% below its average target price of $90.16 after dropping -1.2% during today's morning session. Analysts are giving the large-cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $76.0 to $110.0 per share.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 1.96. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 79.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Vanguard Group Inc | 9% | 116,676,882 | $7,948,029,522 |
| 2023-06-30 | Blackrock Inc. | 7% | 93,734,850 | $6,385,218,239 |
| 2023-06-30 | State Street Corporation | 4% | 55,877,387 | $3,806,367,755 |
| 2023-06-30 | Morgan Stanley | 3% | 33,253,424 | $2,265,223,334 |
| 2023-06-30 | Capital World Investors | 2% | 30,490,802 | $2,077,033,515 |
| 2023-06-30 | Geode Capital Management, LLC | 2% | 23,325,287 | $1,588,918,614 |
| 2023-06-30 | FMR, LLC | 2% | 21,292,797 | $1,450,465,390 |
| 2023-06-30 | Invesco Ltd. | 1% | 17,002,487 | $1,158,209,461 |
| 2023-06-30 | Bank of America Corporation | 1% | 16,551,119 | $1,127,462,271 |
| 2023-06-30 | Dodge & Cox Inc | 1% | 16,024,422 | $1,091,583,670 |
